Join
Live feed
·
INSIDERFilingvia Quantisnow
Opus Genetics Inc. logo

Chief Financial Officer Gagnon Robert E. sold $40,658 worth of shares (7,842 units at $5.18), decreasing direct ownership by 1% to 592,158 units (SEC Form 4) (withholding obligation)

ByQuantisnow·Wall Street's wire, on your screen.
IRD· Opus Genetics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IRD (Opus Genetics Inc.) and more on Quantisnow.